AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2024
May 20, 2024
33298_dirs_2024-05-20_e0eb9a13-3a51-48aa-a958-445cefbac872.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2024-04-26
Reporting Person: MACRAE CALUM ARCHIBALD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-26 | Common Stock | A | 16500 | — | Acquired | 16500 | Direct |
Footnotes
F1: These shares of restricted stock vest on the first anniversary of the grant date.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Capital/Financing Update
2026
Apr 1
Regulatory Filings
2026
Mar 23
Capital/Financing Update
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Earnings Release
2025
Nov 17